Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferiprone in Aneurysmal Subarachnoid Hemorrhage
NCT03754725Phase 2Active, not recruiting
- Sponsor
- Duke University
- Start
- Oct 2020
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of deferiprone in subarachnoid hemorrhage (SAH), sponsored by Duke University. Started Oct 2020; status: active, not recruiting.
02
Drugs
deferiprone
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT03754725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03754725.